UVA Health discusses the bivalent vaccine

Published: Sep. 7, 2022 at 5:54 PM EDT|Updated: Sep. 8, 2022 at 10:41 AM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

CHARLOTTESVILLE, Va. (WVIR) - UVA Health is discussing the Pfizer and Moderna omicron-specific boosters.

The FDA authorized and the CDC endorsed the use of MRNA vaccines from both companies containing two targets: The original 2020 COVID-19 strain and the omicron BA4BA5 subvariant.

“The hope is that since it’s targeting these two strains, that it actually provides a breadth of immunity with a tried and true COVID vaccine,” Doctor Costi Sifri with UVA Health said.

The vaccine is being called bivalent, because it targets two different COVID-19 variants.

Do you have a story idea? Send us your news tip here.